Insider trades
Kathleen Tregoning, Director of Spero Therapeutics SPRO, has filed 0 purchases and 1 sale on the open market. The latest trade was on 06/23.
Kathleen Tregoning
Director
- Company
- Spero Therapeutics SPRO
- First filing
- 23/01/05
- Trades
- 19 trades
- Buys / sales
- 0 / 1
- 12-month net buying
- No record
- Last trade
- 06/23
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 23/12/20 | 23/12/21 | 6,288 sh | $41.42 | $260,448.96 | −45.6% |